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Sequential isolates from eight cynomolgus monkeys experimentally infected with simian immunodeficiency virus (SIVsm,
of sooty mangabey origin) were tested for coreceptor use in the human osteosarcoma indicator cell line, GHOST(3),
expressing CD4 and one or another of the chemokine receptors CCR3, CCR5, CXCR4, BOB, or the orphan receptor Bonzo.
The indicator cell line carries the human immunodeficiency virus type 2 long terminal repeat-driven green fluorescence
protein gene that becomes activated upon infection with HIV or SIV and fluorescence can be quantitated by flow cytometric
analysis. The methodological details are described in the accompanying paper (Vo¨dro¨s et al., 2001, Virology 290, in press).
All SIVsm inoculum viruses and reisolates used CCR5 with a high level of efficiency. CCR5 use was stable over time. BOB
and Bonzo use was less efficient than CCR5 use and, in particular, late isolates obtained at the time of immunodeficiency
varied greatly in their coreceptor use and often could not establish a productive infection in BOB- or Bonzo-expressing cells.
Unexpectedly, early reisolates obtained 12 days postinfection could infect the entire GHOST(3) panel including the parental
cells. In one case this was due to use of CXCR4, either transfected or endogenously expressed on the GHOST(3) cells. Our
results demonstrate the complex coreceptor use of SIVsm isolates. Moreover, they focus attention on the initial phase of
virus replication when the availability of target cells may govern the replication pattern of the virus. © 2001 Elsevier Science
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Simian immunodeficiency virus (SIV) infection in mon-
keys has many similarities to human immunodeficiency
virus (HIV) infection in humans. Using the SIV model in
macaques we may explore the critical steps in disease
progression following infection with a lentivirus causing
immunodeficiency. Earlier studies have shown that the
main receptors for HIV-1 entry into target cells are the
chemokine receptors CCR5 and CXCR4 in conjunction
with CD4 (Deng et al., 1996; Dragic et al., 1996; Feng et
al., 1996). HIV-1 isolates previously called slow/low or
non-syncytium-inducing (NSI) use CCR5, whereas vi-
ruses able to infect established T cell lines, and formerly
called rapid/high or syncytium-inducing (SI), use CXCR4
as coreceptor for cell entry (Bjo¨rndal et al., 1997; Scarlatti
et al., 1997). CXCR4 using HIV-1 isolates are often char-
acterized by dual tropism or multi-tropism and may use
CCR5, CCR3, and CCR2b as well. Like HIV-1, SIV isolates
regularly use CCR5 as coreceptor for cell entry (Chen et
al., 1997; Edinger et al., 1997; Marcon et al., 1997) but,
1 To whom correspondence and reprint requests should be ad-
dressed at Department of Medical Microbiology, Dermatology, and
Infection, Division of Virology, Lund University, So¨lvegatan 23; S-223 62
Lund, Sweden. Fax: 146-46-176-033. E-mail: Dalma.Vodros@mtc.ki.se.
0042-6822/01 $35.00
© 2001 Elsevier Science
All rights reserved.
12unlike HIV-1, use of CXCR4 is rarely found and is largely
dependent on the virus strain used (Owen et al., 2000;
Schols and De Clercq, 1998).
Studies on SIVMne infection in macaques showed that
viral phenotypic changes may occur over time (Rudensey
et al., 1995, 1998). These changes involved neutralizing
antibody recognition, syncytium formation, and macro-
phage tropism of viruses isolated from macaque periph-
eral blood mononuclear cells (PBMC) at different time
points. Virus isolates obtained at the time of AIDS were
resistant to neutralization, induced syncytia in the
CEMx174 cell line, and were poorly infectious for ma-
caque macrophages. These phenotypic changes sug-
gested that SIV, like HIV-1, evolves over the course of
pathogenic infection (Scarlatti et al., 1997).
Our earlier studies on eight experimentally SIVsm- (of
sooty mangabey origin) infected macaques showed that
reisolates obtained various times after infection were
frequently resistant to neutralization with autologous
sera (Zhang et al., 1993). These antigenic changes sug-
gested that phenotypic changes, such as changes in
coreceptor use, may occur in the virus populations over
time. In the present study we therefore tested coreceptor
use of sequential SIVsm isolates from the same eight
cynomolgus macaques differing in the rate of disease
progression. In addition to CCR5, SIV has been shown to
SIVmac
egative
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TYMSTRL (Deng et al., 1997; Edinger et al., 1998a; Farzan
et al., 1997), recently identified as a transmembrane CXC
chemokine receptor (Matloubian et al., 2000). BOB and
Bonzo use is rare among HIV-1 isolates. A series of cell
lines with stable expression of CD4 and one or another
of the orphan receptor BOB or the chemokine receptors
CCR3, CCR5, CXCR4, or Bonzo was available from the
GHOST(3) series (Cecilia et al., 1998; Mo¨rner et al., 1999)
and was used in the present experiments. In the accom-
panying paper (Vo¨dro¨s et al., 2001) we describe the
validation of the GHOST(3) indicator system for use with
HIV-1. In the present work we used the same indicator
cell system and asked the question of whether changes
in coreceptor use of SIVsm reisolates occur over time.
RESULTS
Coreceptor usage of SIVsm inoculum viruses
Entry of viruses into the indicator cells expressing
different coreceptors was measured by the extent of
green fluorescence protein (GFP) induction. The ability to
establish productive infection following entry was esti-
mated by viral antigen production in the culture fluids 6
days postinfection.
Regardless of in vitro passage history, all inoculum
FIG. 1. Coreceptor use of inoculum viruses. GHOST(3) cell lines w
uninfected control cells (for definition of RTCN see Materials and
experimental variation is shown by the bars at the top of each column.
tests positive; 2, both tests negative; 6, one test positive, the other nviruses used CCR5, BOB, and Bonzo, like uncloned SIV-
mac (Fig. 1). (For a detailed history of inoculum virusessee Materials and Methods.) The experimental variation
of the extent of GFP induction, characterized by the
calculated RTCN value (ratio to cell negative; see details
of calculation under Materials and Methods) and indi-
cated by the bars on the top of each column, did not
exceed 0.75 log. In fact, RTCN values for a given virus–
receptor combination repeatedly scored positive (or
were repeatedly negative). Remarkably, SIVsmB, but not
SIVsmA and C, was able to infect CXCR4-expressing
cells. It must be remembered that SIVsmB had been
maintained in passage in human peripheral blood mono-
nuclear cells (hPBMC) for 3 months prior to use in the
present experiments. Since cultured hPBMC express
CXCR4 more abundantly than CCR5 (Bleul et al., 1997),
the SIVsmB virus could have been selected for CXCR4
use. In line with this, SIVsmB scored positive on the
parental GHOST(3) cells as well, known to have a low
level of spontaneous expression of CXCR4. This may
also account for the apparent CCR3 use by this virus.
Interestingly, SIVsmC with the shortest passage history
in hPBMC was the least able to use CXCR4.
Viruses that scored positive for coreceptor usage by
GFP induction could also establish a productive infection
in the corresponding GHOST(3) cell lines, as shown by
antigen production in supernatant culture fluids (Fig. 1). It
must be noted that SIVsmA in CCR3-expressing cells
showed indeterminate RTCN but produced antigen, al-
cted with 56–96 ID50. The columns indicate the fold difference from
s) and represent the mean of two independent experiments. The
251 was tested only once. Results of viral antigen production: 1, both
; *, not determined.ere infe
Methodbeit small amounts, in both experiments. On the other
hand, SIVsmB with positive RTCN on CCR3-expressing
d from
14 VO¨DRO¨S ET AL.cells and SIVsmC on Bonzo-expressing cells produced
viral antigen in one of two experiments only.
Coreceptor usage of sequential reisolates
We tested 3 isolates each from five monkeys, 2 iso-
lates each from two monkeys that died within 6 months
postinfection, and the 1 isolate that could be recovered
from a long-term survivor monkey: altogether 20 isolates.
Four monkeys (MF6, MF8, MF9, and MF10) were infected
with the SIVsmA virus, whereas SIVsmB and SIVsmC
were inoculated to two monkeys each (H9, H56 and H27,
H28, respectively).
Entry, Measured as GFP Induction. The first reisolates
obtained 12 days postinfection used CCR5, BOB, and
Bonzo as coreceptors, like the inoculum viruses (Fig. 2).
As expected, virus reisolated from the SIVsmB-infected
monkey (H9) appeared to use CXCR4 and CCR3 as well,
like the SIVsmB inoculum virus. However, it was unex-
pected that 12-day reioslates from monkeys inoculated
with SIVsmA—which itself gave indeterminate RTCN val-
ues on CXCR4- and CCR3-expressing cells—induced
GFP in all indicator cells including the GHOST(3) paren-
tal cells (Fig. 2). Even the first reisolate from monkey H27,
inoculated with SIVsmC, gave positive results on CCR3-
FIG. 2. Coreceptor use of 20 reisolates obtaineexpressing cells, although the RTCN was 10.9, just above
the cut-off level (Fig. 2).The capacity to induce GFP in CXCR4-expressing cells
decreased over time and was in all cases absent when
reisolates obtained shortly before the animals’ death
from immunodeficiency were tested (Fig. 2). Similar re-
sults were obtained on the parental cells and with two
exceptions (indeterminate results of the third isolates
from monkeys MF6 and MF10) on the CCR3-expressing
cell line. In contrast, CCR5 use and, to some extent, BOB
use were stable during infection and reisolates obtained
at different times after infection seemed to use these
coreceptors with similar high efficiency (Fig. 2). The ca-
pacity to use Bonzo showed minor variations (1.15 log)
among the 12-day reisolates but diverged later on (2.15
log variation before the death of animals). In fact, the late
reisolates from monkeys MF8 and H28 lost their ability to
use Bonzo. The only isolate available from monkey H56,
obtained 912 days postinfection, used CCR5 and BOB as
coreceptors for cell entry.
Productive Infection, Measured as Antigen Production
in Culture Supernatants. Infection of CCR5-expressing
cells resulted in production of large amounts of antigen
in the majority of cases (Table 1). Antigen production
from the parental GHOST(3) cells or cells expressing
CXCR4, CCR3, BOB, or Bonzo varied according to the
experimentally infected macaques over time.time of reisolation (data not shown). Accordingly, cultures
infected with the 12-day reisolates produced virus in
m 19 v
. The f
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induce GFP, did not produce antigen in any but CCR5-
expressing cells. This indicates that early reisolates
showed higher replicative capacity in the GHOST(3) in-
dicator cells than late reisolates. The results also show
that GFP induction in GHOST(3) cells is more sensitive
for detection of SIVsm infection than antigen production.
Inhibition of CXCR4-using viruses with AMD3100
To estimate the contribution of endogenous CXCR4
expression on virus entry, we treated GHOST(3) cells
T
Viral Antigen Production in
Antigen OD490
b
CCR5
% of isolates Mean RTCN (SD) % of
.3 45 391.9 (226.4)
1.5–2.99 23 140.5 (97.2)
0.5–1.49 23 203.3 (116.9)
0.1–0.49 9 111.4 (29.1)
,0.1 0 —
a Data from 22 isolates for CCR5- and BOB-expressing cells and fro
b Supernatant culture fluids were assayed for viral antigen by ELISA
FIG. 3. Inhibition of virus infection by AMD3100 (1 mg/ml). GFP induct
cytometry 3 days postinfection. The control HIV-1 virus is a dual-tropic R
and with AMD3100 (bottom number) is indicated in each diagram. Continuous
in the presence of AMD3100. M1 denotes 0.1% fluorescence-positive cells inwith the specific CXCR4 antagonist, AMD3100, prior to
infection. CXCR4 use of a control virus, a HIV-1 isolate of
R5X4 phenotype, was effectively inhibited by AMD3100
(Fig. 3). In this case the RTCN value decreased from 146
to 1.3 in exogenous CXCR4-expressing cells and from 33
to 1.8 in parental cells, resulting in a 2.04 and 1.28 log
inhibition, respectively. AMD3100 also inhibited CXCR4
use by the first reisolate from monkey H9 (H9:12) and the
corresponding SIVsmB inoculum virus. The reduction in
RTCN values was 1.08 and 1.12 log, respectively, in
CXCR4-expressing cells, decreasing RTCN to a still pos-
scence-Positive Culturesa
BOB Bonzo
s Mean RTCN (SD) % of isolates Mean RTCN (SD)
— 0 —
— 0 —
59.7 (14.6) 26 320.3 (64.4)
77.7 (43.8) 42 119.7 (49.9)
28.9 (20.9) 32 65.7 (39.8)
irus isolates for Bonzo-expressing cells that gave RTCN values .10.
igures denote optical density (OD) measured at 490 nm.
HOST(3) parental, CCR5- or CXCR4-expressing cells analyzed by flow
late. The proportion of fluorescence-positive cells without (top number)ABLE 1
Fluore
isolate
0
0
14
68
18ion in G
5X4 isoline: infection in the absence of AMD3100, discontinuous line: infection
the uninfected control cultures.
B (n )
16 VO¨DRO¨S ET AL.itive value (19.8 and 19.4, respectively). However, the
drug proved ineffective on infection of the parental cells
with these viruses (Fig. 4). Compared to the complete
inhibition of CXCR4 use of HIV-1, infection by SIVsmB and
H9:12 was only partially inhibited by AMD3100. This
result suggests that a CXCR4-using virus can be recov-
ered early after infection from a monkey infected with a
virus that was able to use CXCR4. In addition, SIVsmB
and the H9:12 isolates seem to be able to use an-
other—as yet unidentified—coreceptor, as suggested
by the partial inhibition obtained with AMD3100. Whether
CXCR4 or another unidentified receptor was expressed
on the GHOST(3) cells, the capacity to use any of these
receptors was reduced over time in the macaques.
Infection via CCR5 is more effective than via the BOB
or Bonzo coreceptors
As shown in Figs. 1 and 2, all three inoculum viruses and
the 20 reisolates from eight monkeys used CCR5 and BOB
and, with the exception of 3, also used Bonzo as coreceptor
for cell entry. Interestingly, the proportion of fluorescence-
positive cells was higher on GHOST(3).CCR5 cells than on
BOB- or Bonzo-expressing cells (Fig. 4). GHOST(3).CCR5
cultures also produced larger amounts of viral antigen (Ta-
ble 1) in that about 90% of the viruses produced viral
antigen with optical density (OD) values higher than 0.5. In
contrast, infection with the same viruses resulted in a high
FIG. 4. Comparison of the efficiency of CCR5 (), Bonzo (}), and BO
and their fluorescence intensity ( y).level of viral antigen production in only 14% of BOB- and
26% of Bonzo-expressing cell cultures. This indicates thatmany of the fluorescent GHOST(3).BOB and Bonzo cultures
did not produce virus or produced very little virus (OD ,
0.5). Discordant GFP induction and antigen production
were particularly striking with reisolates obtained at the
time of overt immunodeficiency. In fact, only 12-day reiso-
lates produced amounts .0.5 OD from Bonzo-expressing
cells, similarly to the inoculum viruses. The results indicate
that SIVsm inoculum viruses and reisolates efficiently use
CCR5 and establish a productive infection following entry
into cells. In contrast, infection by the BOB or Bonzo core-
ceptors is less efficient, and the capacity to establish a
productive infection decreases over time.
DISCUSSION
Our results show that viruses reisolated from cynomol-
gus macaques following intravenous inoculation of
SIVsm use CCR5, BOB, and Bonzo as coreceptors for cell
entry. In addition, and depending on the passage history
of the inoculum virus, CXCR4 use could be demonstrated
with one inoculum virus and a corresponding early re-
isolate. Interestingly, CXCR4 use was only partially inhib-
ited by AMD3100, a specific CXCR4 antagonist, when
these two isolates were tested, suggesting the use of
another receptor that remains to be identified.
Even if early reisolates induced GFP in parental or
CXCR4- and CCR3-expressing GHOST(3) cells, subse-
quent reisolates gradually lost this ability, suggesting
use as a function of the percentage of fluorescence positive cells ( x)that this phenotype is not favored or may even be se-
lected against. One possibility is that the initial target
17CORECEPTOR USE OF SEQUENTIAL SIVsm ISOLATEScells for SIVsm replication had decreased in number or
had been eliminated as a consequence of virus replica-
tion. Veazey et al. (1998) found that activated memory
T-lymphocytes in the lamina propria of the intestinal
epithelium are the initial target cells for SIVmac replica-
tion. Infection of rhesus monkeys resulted in a profound
and selective depletion of CD41 T-cells in the intestine
during the first 2–3 weeks of infection (Smit-McBride et
al., 1998; Veazey et al., 1998). It is conceivable that de-
pletion of the activated memory CD41 cells causes a
shortage in the preferred target cells available for virus
replication. If so, this would explain the initial decrease
in viral load, particularly in tissues (Veazey et al., 1998).
Following initial depletion of the preferred target cells,
other cells, like naive lymphocytes and macrophages,
available at the same site or other sites, may express
receptors for inflammatory chemokines, in the first place
CCR5. It has been shown that the cytokine environment
regulates cytokine receptor expression and occupancy
and, as a consequence, also determines the suscepti-
bility of macrophages to HIV or SIV infection (Wang et al.,
1998; Wu et al., 1997). Indeed, early inflammatory re-
sponses involving RANTES production in tissues of SIV-
infected macaques have been described (Cheret et al.,
1999). In addition, phenotypic changes in peripheral
blood monocytes of infected macaques have also been
described (Otani et al., 1998; Zhou et al., 1999), perhaps
leading to an increase in the availability of CCR5-ex-
pressing cells. According to this scenario, lymphocytes
that are continuously recruited to the organized lymphoid
tissue become activated by antigenic stimulation and
provide new target cells for SIV infection. However, these
new target cells express CCR5 and favor replication of
CCR5-using viruses. This would then predict profound
changes in the biological phenotype of SIV replicating
initially and at later times. Moreover, the early phase of
SIV infection seems to be crucial in establishing the in
vivo replication pattern and associated clinical course in
infected macaques. Lifson et al. (1997) suggested that
host factors that exert their effects prior to development
of specific immune responses, like susceptibility of ma-
caque cells to infection (measured in vitro in their exper-
iments), are critical in determining the set points for
subsequent plasma viremia and thereby determine pro-
gression rate. In this respect, it is noteworthy that HIV-
1-infected individuals have a significantly greater per-
centage of CCR5- than CXCR4-expressing CD41 T-cells
in blood as compared to normal controls (Ostrowski et
al., 1998).
Recent findings show that the Tat protein, secreted by
HIV-1-infected cells, is a specific CXCR4 antagonist that
selectively inhibits the entry and replication of X4, but not
R5, viruses in PBMC and may influence the early in vivo
course of disease (Xiao et al., 2000). It is possible that Tat
is an antagonist also for the as yet undefined coreceptorused by our isolates. If so, this would explain the de-
creasing efficiency of the use of this latter coreceptor.
An alternative scenario takes into consideration the
immune response of the host. Mattapallil et al. (1998)
detected larger numbers of SIV-positive cell during pri-
mary acute and terminal stages of SIV infection com-
pared to the asymptomatic stage. It is conceivable that in
the very early, acute phase of infection, at the time of
high-level viral replication, even CXCR4-using viruses
are allowed to replicate in the naive CD41 cells, known
to express CXCR4 (Bleul et al., 1997). In a few weeks an
effective immune response (including T-cell activation) is
generated against the virus (Mattapallil et al., 2000),
causing a decrease in the number of infected cells.
Conceivably, the immune response in conjunction with
the phenotype of the available target cells may exert a
selective pressure on the virus population. Conse-
quently, the coreceptor usage pattern of the initially rep-
licating viruses may differ from that of the viruses en-
countered later on.
No consistent change in coreceptor use preceding or
concurring with immunodeficiency could be observed in
our experiments. This is in line with SIVMne infection
where no change in the ability of reisolated virus to use
CCR5 (Rudensey et al., 1998) or CCR5 and BOB (Kimata
et al., 1999) could be observed. Indeed, the high level of
efficiency of CCR5 use by the SIVsm reisolates was
remarkably constant over time, regardless of the disease
progression rate of our macaques. Similarly to Edinger et
al. (1998a), we also found that CCR5 use is more efficient
than either BOB or Bonzo use. In our hands the capacity
to use BOB was maintained but it became less efficient
over time, since the ability of the reisolates to establish
productive infection in the GHOST(3) cells was highest
early in infection and decreased later. Bonzo use
changed to an even larger extent than BOB use, in that
reisolates obtained from three animals 1–2 years postin-
fection lacked the capacity to use Bonzo altogether.
Characteristically, GFP induction-positive/antigen pro-
duction-negative cultures were obtained upon infection
with late reisolates. Chackerian et al. (1997) have sug-
gested that interactions among the coreceptor(s), the
viral envelope, and another, not yet identified, viral gene
product may govern post-entry steps of viral replication.
In view of the extensive genetic variation of SIV in in-
fected macaques (Campbell and Hirsch, 1994; Hirsch et
al., 1990, 1991; Johnson and Hirsch, 1992; Kodama et al.,
1993; Mori et al., 1992), this hypothetical viral gene is also
likely to vary. If so, this could explain the increase in the
proportion of discordant cultures with late reisolates.
It is once again interesting to note how in vitro pas-
sage history influences coreceptor use of SIVsm isolates
(Hirsch et al., 1989). Clearly, prolonged passage in hu-
man PBMC selected for virus able to use CXCR4. We
know today that CXCR4 expression is more abundant in
hPBMC cultures than CCR5 expression (Bleul et al.,
18 VO¨DRO¨S ET AL.1997) and this may favor replication via the CXCR4 re-
ceptor. SIVsmB is a clear example of a CXCR4-using
virus. This is in agreement with the findings of Hoffman
et al. (1998), who infected macaques with simian HIV
(SHIV) containing a X4 HIV-1 Env protein. The results
show that CXCR4 can function as a coreceptor in ma-
caques even though it is rarely used by simian immuno-
deficiency virus. Based on our results we may suggest
that the CXCR4-using phenotype is not favored or may
even be selected against in vivo. The best example is
monkey H9, which was infected with SIVsmB and yielded
a CXCR4-using virus early after infection but not 6
months later.
Taken together, our results show that changes in co-
receptor use of SIVsm occur during pathogenic infection.
Isolates from the initial phase of virus replication from
five of seven monkeys tested were able to infect all
GHOST(3) sublines; however, this ability was gradually
lost over time. Since this pattern was similar in all mon-
keys tested, regardless of serum neutralizing activity to
autologous virus, we suggest that the availability of tar-
get cells governs the replication pattern of the virus.
CXCR4-using virus could be isolated early after infection
from a monkey inoculated with an isolate able to use
CXCR4. CCR5 use of viruses recovered from the animals
was highly efficient and stable over time, perhaps reflect-
ing the profound and long-standing inflammatory re-
sponse concomitant with SIVsm infection. Our continued
efforts are focused on the identification of the suspected
unknown receptor. Candidate receptors may be Apj,
Gpr1, ChemR23, and RDC1 (Choe et al., 1998; Edinger et
al., 1998a,b; Eva and Sprengel, 1993; Methner et al., 1997;
Mo¨rner et al., 1999; Owman et al., 1997; Shimizu et al.,
2000; Singh et al., 1999; Zhang and Moore, 1999) and will
be probed for their relevance in SIVsm pathogenesis.
Although obtained in the macaque model, our results
may be relevant for HIV-1 pathogenesis and, once again,
focus attention on the phase of intial virus replication,
which might be critical in determining disease progres-
sion. The monkey model has the advantage of allowing
dissection of this early phase of infection.
MATERIALS AND METHODS
Animals and viruses
The SIVsm (strain SMM-3) isolate was kindly provided
by P. Fultz and H. McClure, Yerkes Regional Primate
Research Center (Atlanta, GA). It was originally isolated
from a naturally infected sooty mangabey monkey (Cer-
cocebus atys) (Fultz et al., 1986). This virus had been
grown on the human T-cell line, HUT-78, followed by two
passages in hPBMC (Putkonen et al., 1989). Cell-free
supernatant of hPBMC cultures, harvested 8 days after
infection, was the source of inoculum A. Inoculum B was
derived from inoculum A by further passage on hPBMC
for 3 months. Inoculum C was derived from a cynomol-gus macaque that had been infected with inoculum A
and developed diarrhea, weight loss, and tachypnea 245
days postinoculation. Virus was isolated from the mon-
key’s PBMC by cocultivation with hPBMC and the cell-
free supernatant of this coculture was used as inoculum
C. SIVmac251-infected HUT-78 cells were obtained from
M. Essex (Harvard Medical School, Boston, MA). The
HIV-1 control virus used in the inhibition experiments
was a Cameroonian subtype B/D isolate, known to use
both CCR5 and CXCR4 coreceptors (Tscherning-Casper
et al., 2000).
Eight cynomolgus monkeys were inoculated intrave-
nously, four with SIVsmA (MF6, MF8, MF9, MF10), two
with SIVsmC (H27, H28), and two with SIVsmB (H9, H56)
(Zhang et al., 1993). Two monkeys (H9 and H27) were fast
progressors and died of immunodeficiency within 6
months, whereas two monkeys (H28 and H56) were
long-term survivors and were sacrificed with immunode-
ficiency after 39 and 30 months, respectively. Seven
monkeys (MF6, MF8, MF9, MF10, H27, H28, and H9) had
lymphadenopathy and weight loss (4–35%). Monkeys
MF6 and MF10 had neurological symptoms; monkey
MF9 had diarrhea. Monkey H56 did not show any clinical
symptoms up to 730 days postinfection but developed
immunodeficiency afterward. After a transient decrease,
the CD4 cell count returned to normal levels in this
monkey. In contrast, in the fast progressor monkeys (H9
and H27) the CD4 level decreased rapidly and perma-
nently.
Blood samples were collected from the monkeys at
regular intervals and virus isolations were carried out 12,
126–226, and, if possible, 316–607 days after infection. In
the case of monkey H56, the only virus isolate available
was obtained 912 days postinfection. In total 20 isolates
from eight monkeys were available and tested along with
the three inoculum viruses for coreceptor use. Reisolates
were passaged on hPBMC no more than three times.
Cell-free supernatants from the hPBMC (Weber et al.,
1996) cultures were titrated on hPBMC, and 252 ID50
(6158) (infectious dose-50) were used for infection of
GHOST(3) cells.
Cell lines
Human osteosarcoma cell lines, GHOST(3) engi-
neered to stably express the CD4 receptor, and one or
another of the chemokine receptors CCR3, CCR5,
CXCR4, Bonzo, or the orphan receptor BOB were used
(Cecilia et al., 1998; Mo¨rner et al., 1999). The parental cell
line had been engineered to express CD4 but none of the
coreceptors. However, clone 3 used in our experiments
is known to have a low level of spontaneous expression
of CXCR4. The cells were stably transfected with the
gene of the GFP driven by the HIV-2ROD long terminal
repeat (LTR). In case of infection, when the virus enters
the cells by using CD4 and the given coreceptor, the viral
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scription of the GFP gene by the LTR. GFP expression in
infected cells is easily detected in a fluorescence micro-
scope and by flow cytometry. The GHOST(3) cell lines
were maintained in Dulbecco’s modified Eagle’s medium
(Life Technologies, Palsley, Scotland) containing 7.5%
fetal calf serum (Life Technologies, Karlsruhe, Germany)
and antibiotics and incubated in a humidified atmo-
sphere with 5% CO2 at 37°C. Cells were detached by
treatment with 5 mM EDTA solution and the cultures
were split 1:15 twice a week.
Infection of GHOST(3) cells
One day before infection 24-well plates were prepared
with 2–3 3 104 cells/well in 1 ml medium. Before infec-
tion, medium was replaced with 200 ml fresh medium
and virus was added to duplicate wells in a volume of
300 ml/well. Two hours after infection, medium was
added up to 1 ml/well. After an overnight incubation,
cells were washed with PBS (PBS Dulbecco’s, Life Tech-
nologies, Palsley, Scotland), 1 ml medium was added to
each well, and the plates were further incubated. Three
days after infection cultures were examined in a fluores-
cence microscope and cells from one of the parallel
wells were harvested and prepared for flow cytometry by
adding paraformaldehyde to a final concentration of 2%
for at least 2 h. Remaining wells were split 1:5–1:10 and
cultures were maintained for another 3 days for viral
antigen detection by ELISA.
In one series of experiments the specific CXCR4 an-
tagonist AMD3100 was used (Schols et al., 1997).
AMD3100 was added to the cells prior to infection in 200
ml medium at a concentration of 1 mg/ml and virus was
added 5 min later. Parallel wells without inhibitor were
included in each experiment and treated in the same
way.
Flow cytometry
Flow cytometric analysis and its validation are de-
scribed in the accompanying paper (Vo¨dro¨s et al., 2001).
Briefly, infected GHOST(3) cells were detached from the
wells by EDTA treatment, fixed by paraformaldehyde, and
then analyzed by flow cytometry (FACScan, Beckton
Dickinson). The GHOST(3) cell population was selected
on the side scatter–forward scatter diagram, and the
fluorescence intensity of 1.5 3 104 GHOST(3) cells was
measured. For quantitative determination of the effi-
ciency of coreceptor use a characteristic number, RTCN
(ratio to cell negative), was calculated for each virus–
coreceptor combination
RTCN 5 (FI 3 %)virus/(FI 3 %) neg.control,
where % is the proportion of fluorescence-positive cells
and FI is the mean fluorescence intensity of the fluores-
cence-positive cells. Negative controls were mock-in-fected cultures from the corresponding coreceptor-ex-
pressing cell line. RTCN values above 10 scored positive,
indicating use of the particular coreceptor. RTCN below 5
scored negative, while a RTCN value between 5 and 10
was considered indeterminate. The results obtained by
flow cytometry strictly correlated to those of microscopy.
For details of evaluation see the accompanying paper
(Vo¨dro¨s et al., 2001).
SIV antigen detection
To detect viral antigens produced by the infected cells
an in-house HIV-2/SIV capture enzyme-linked immu-
nosorbent assay (ELISA) was used (Thorstensson et al.,
1991). In brief, cell-free supernatants from the cultures
were added to 96-well microtiter plates previously
coated with purified immunoglobulin-G from an asymp-
tomatic HIV-2-positive blood donor and blocked with 1%
bovine serum albumin. Captured SIV antigen was de-
tected with rabbit anti-SIVmac serum followed by a
horseradish peroxidase-conjugated swine and anti-rab-
bit immunoglobulin. Subsequently, the o-phenylenedi-
amine substrate with H2O2 was added. The reaction was
stopped with 2.5 M H2SO4 and the optical density was
measured at 490 nm wavelength (OD490). Viral antigen
production was scored positive when OD490 values were
above an absorbance value of 0.1.
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